Specialized Medical CompanyTADAWUL: 4019

Specialized Medical Company: Net profit fell 40% on higher costs, with IPO and dividend reversals marking a pivotal quarter

· Issued by Specialized Medical Company

Revenue grew slightly year-over-year, but net profit declined nearly 40% due to higher expenses and lower margins. The Group is preparing for a June 2025 IPO and reversed SR 200 million in interim dividends, requiring shareholder repayment.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis